Tag:
ATX-101
Latest Headlines
Latest Headlines
Kythera lands $37M D round for PhIII fat-zapping study
A group of some of the top venture funds in life sciences has banded together to back a $37.4 million D round for Los Angeles-based Kythera Biopharmaceuticals as the aesthetic medicine biotech
Bayer, Kythera ink $373M dermatology deal
Los Angeles-based Kythera Biopharmaceuticals has landed a $373 million licensing deal with Bayer Healthcare's dermatology unit Intendis. The group gets rights to Kythera's lead product candidate,
